174 related articles for article (PubMed ID: 19922576)
1. The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients.
Van Schayck CP; Kaper J; Wagena EJ; Wouters EF; Severens JL
Addiction; 2009 Dec; 104(12):2110-7. PubMed ID: 19922576
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.
Wagena EJ; Knipschild PG; Huibers MJ; Wouters EF; van Schayck CP
Arch Intern Med; 2005 Oct; 165(19):2286-92. PubMed ID: 16246996
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.
Quaak M; van Schayck CP; Postma DS; Wagena EJ; van Schooten FJ
Addiction; 2012 Jan; 107(1):178-87. PubMed ID: 21658141
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
Linden K; Jormanainen V; Linna M; Sintonen H; Wilson K; Kotomäki T
Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
Hoogendoorn M; Welsing P; Rutten-van Mölken MP
Curr Med Res Opin; 2008 Jan; 24(1):51-61. PubMed ID: 18021492
[TBL] [Abstract][Full Text] [Related]
6. The effect of a minimal contact smoking cessation programme in out-patients with chronic obstructive pulmonary disease: a pre-post-test study.
Monninkhof E; van der Valk P; van der Palen J; Mulder H; Pieterse M; van Herwaarden C; Zielhuis G
Patient Educ Couns; 2004 Mar; 52(3):231-6. PubMed ID: 14998591
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of an intensive smoking cessation intervention for COPD outpatients.
Christenhusz LC; Prenger R; Pieterse ME; Seydel ER; van der Palen J
Nicotine Tob Res; 2012 Jun; 14(6):657-63. PubMed ID: 22180589
[TBL] [Abstract][Full Text] [Related]
8. Bupropion for smokers hospitalized with acute cardiovascular disease.
Rigotti NA; Thorndike AN; Regan S; McKool K; Pasternak RC; Chang Y; Swartz S; Torres-Finnerty N; Emmons KM; Singer DE
Am J Med; 2006 Dec; 119(12):1080-7. PubMed ID: 17145253
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation.
Hall SM; Lightwood JM; Humfleet GL; Bostrom A; Reus VI; Muñoz R
J Behav Health Serv Res; 2005; 32(4):381-92. PubMed ID: 16215448
[TBL] [Abstract][Full Text] [Related]
10. A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas.
Hill A
Tex Med; 2006 Aug; 102(8):50-5. PubMed ID: 17115560
[No Abstract] [Full Text] [Related]
11. Review of bupropion for smoking cessation.
Richmond R; Zwar N
Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907
[TBL] [Abstract][Full Text] [Related]
12. Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
Bolin K; Mörk AC; Willers S; Lindgren B
Respir Med; 2008 May; 102(5):699-710. PubMed ID: 18289839
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Lutz MA; Lovato P; Cuesta G
Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
[TBL] [Abstract][Full Text] [Related]
14. What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD?
Kotz D; Huibers MJ; West RJ; Wesseling G; van Schayck OC
Patient Educ Couns; 2009 Jul; 76(1):16-24. PubMed ID: 19150590
[TBL] [Abstract][Full Text] [Related]
15. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results.
Haggsträm FM; Chatkin JM; Sussenbach-Vaz E; Cesari DH; Fam CF; Fritscher CC
Pulm Pharmacol Ther; 2006; 19(3):205-9. PubMed ID: 16517193
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.
Fossati R; Apolone G; Negri E; Compagnoni A; La Vecchia C; Mangano S; Clivio L; Garattini S;
Arch Intern Med; 2007 Sep; 167(16):1791-7. PubMed ID: 17846399
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
[TBL] [Abstract][Full Text] [Related]
19. Nortriptyline for smoking cessation: a review.
Hughes JR; Stead LF; Lancaster T
Nicotine Tob Res; 2005 Aug; 7(4):491-9. PubMed ID: 16085520
[TBL] [Abstract][Full Text] [Related]
20. Non-nicotine pharmacotherapies for smoking cessation.
McRobbie H; Lee M; Juniper Z
Respir Med; 2005 Oct; 99(10):1203-12. PubMed ID: 16011894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
